Literature DB >> 11992561

Endophenotypes in bipolar disorder.

Robert H Lenox1, Todd D Gould, Husseini K Manji.   

Abstract

The search for genes in bipolar disorder has provided numerous genetic loci that have been linked to susceptibility to developing the disorder. However, because of the genetic heterogeneity inherent in bipolar disorder, additional strategies may need to be employed to fully dissect the genetic underpinnings. One such strategy involves reducing complex behaviors into their component parts (endophenotypes). Abnormal neurophysiological, biochemical, endocrinological, neuroanatomical, cognitive, and neuropsychological findings are characteristics that often accompany psychiatric illness. It is possible that some of these may eventually be useful in subdefining complex genetic disorders, allowing for improvements in diagnostic assessment, genetic linkage studies, and development of animal models. Findings in patients with bipolar disorder that may eventually be useful as endophenotypes include abnormal regulation of circadian rhythms (the sleep/wake cycle, hormonal rhythms, etc.), response to sleep deprivation, P300 event-related potentials, behavioral responses to psychostimulants and other medications, response to cholinergics, increase in white matter hyperintensities (WHIs), and biochemical observations in peripheral mononuclear cells. Targeting circadian rhythm abnormalities may be a particularly useful strategy because circadian cycles appear to be an inherent evolutionarily conserved function in all organisms and have been implicated in the pathophysiology of bipolar disorder. Furthermore, lithium has been shown to regulate circadian cycles in diverse species, including humans, possibly through inhibition of glycogen synthase kinase 3-beta (GSK-3beta), a known target of lithium. Published 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11992561     DOI: 10.1002/ajmg.10360

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  55 in total

1.  Chronic treatment with a selective inhibitor of casein kinase I delta/epsilon yields cumulative phase delays in circadian rhythms.

Authors:  Jeffrey Sprouse; Linda Reynolds; Robin Kleiman; Barbara Tate; Terri A Swanson; Gary E Pickard
Journal:  Psychopharmacology (Berl)       Date:  2010-04-21       Impact factor: 4.530

Review 2.  A Comprehensive Overview of Skeletal Phenotypes Associated with Alterations in Wnt/β-catenin Signaling in Humans and Mice.

Authors:  Kevin A Maupin; Casey J Droscha; Bart O Williams
Journal:  Bone Res       Date:  2013-03-29       Impact factor: 13.567

Review 3.  Neuroimaging endophenotypes: strategies for finding genes influencing brain structure and function.

Authors:  David C Glahn; Paul M Thompson; John Blangero
Journal:  Hum Brain Mapp       Date:  2007-06       Impact factor: 5.038

Review 4.  Animal models of bipolar disorder and mood stabilizer efficacy: a critical need for improvement.

Authors:  Todd D Gould; Haim Einat
Journal:  Neurosci Biobehav Rev       Date:  2007-05-31       Impact factor: 8.989

Review 5.  Circadian genes, rhythms and the biology of mood disorders.

Authors:  Colleen A McClung
Journal:  Pharmacol Ther       Date:  2007-02-28       Impact factor: 12.310

Review 6.  Nuclear receptor Rev-erbα: up, down, and all around.

Authors:  Logan J Everett; Mitchell A Lazar
Journal:  Trends Endocrinol Metab       Date:  2014-07-22       Impact factor: 12.015

Review 7.  Electrophysiological Endophenotypes for Schizophrenia.

Authors:  Emily M Owens; Peter Bachman; David C Glahn; Carrie E Bearden
Journal:  Harv Rev Psychiatry       Date:  2016 Mar-Apr       Impact factor: 3.732

Review 8.  Arguments for the sake of endophenotypes: examining common misconceptions about the use of endophenotypes in psychiatric genetics.

Authors:  David C Glahn; Emma E M Knowles; D Reese McKay; Emma Sprooten; Henriette Raventós; John Blangero; Irving I Gottesman; Laura Almasy
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2014-01-24       Impact factor: 3.568

9.  Association study of 21 circadian genes with bipolar I disorder, schizoaffective disorder, and schizophrenia.

Authors:  Hader A Mansour; Michael E Talkowski; Joel Wood; Kodavali V Chowdari; Lora McClain; Konasale Prasad; Debra Montrose; Andrea Fagiolini; Edward S Friedman; Michael H Allen; Charles L Bowden; Joseph Calabrese; Rif S El-Mallakh; Michael Escamilla; Stephen V Faraone; Mark D Fossey; Laszlo Gyulai; Jennifer M Loftis; Peter Hauser; Terence A Ketter; Lauren B Marangell; David J Miklowitz; Andrew A Nierenberg; Jayendra Patel; Gary S Sachs; Pamela Sklar; Jordan W Smoller; Nan Laird; Matcheri Keshavan; Michael E Thase; David Axelson; Boris Birmaher; David Lewis; Tim Monk; Ellen Frank; David J Kupfer; Bernie Devlin; Vishwajit L Nimgaonkar
Journal:  Bipolar Disord       Date:  2009-11       Impact factor: 6.744

Review 10.  The phenomenology of bipolar disorder: what drives the high rate of medical burden and determines long-term prognosis?

Authors:  Isabella Soreca; Ellen Frank; David J Kupfer
Journal:  Depress Anxiety       Date:  2009       Impact factor: 6.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.